BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28668879)

  • 1. Correlation Between Minimum Apparent Diffusion Coefficient (ADC
    Surov A; Meyer HJ; Wienke A
    Anticancer Res; 2017 Jul; 37(7):3807-3810. PubMed ID: 28668879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between Different ADC Fractions, Cell Count, Ki-67, Total Nucleic Areas and Average Nucleic Areas in Meningothelial Meningiomas.
    Surov A; Caysa H; Wienke A; Spielmann RP; Fiedler E
    Anticancer Res; 2015 Dec; 35(12):6841-6. PubMed ID: 26637905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogram analysis parameters of apparent diffusion coefficient reflect tumor cellularity and proliferation activity in head and neck squamous cell carcinoma.
    Surov A; Meyer HJ; Winter K; Richter C; Hoehn AK
    Oncotarget; 2018 May; 9(34):23599-23607. PubMed ID: 29805759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 1: ADC
    Surov A; Meyer HJ; Wienke A
    Oncotarget; 2017 Sep; 8(43):75434-75444. PubMed ID: 29088879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 2: ADC
    Surov A; Meyer HJ; Wienke A
    Oncotarget; 2018 Feb; 9(9):8675-8680. PubMed ID: 29492226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole lesion histogram analysis of meningiomas derived from ADC values. Correlation with several cellularity parameters, proliferation index KI 67, nucleic content, and membrane permeability.
    Surov A; Hamerla G; Meyer HJ; Winter K; Schob S; Fiedler E
    Magn Reson Imaging; 2018 Sep; 51():158-162. PubMed ID: 29782920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.
    Surov A; Meyer HJ; Schob S; Höhn AK; Bremicker K; Exner M; Stumpp P; Purz S
    Oncotarget; 2017 Apr; 8(17):28285-28296. PubMed ID: 28423698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Metabolo-Volumetric Parameters of
    Surov A; Meyer HJ; Höhn AK; Sabri O; Purz S
    Transl Oncol; 2019 Jan; 12(1):8-14. PubMed ID: 30240972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis.
    Surov A; Meyer HJ; Wienke A
    Oncotarget; 2017 Aug; 8(35):59492-59499. PubMed ID: 28938652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-Weighted Imaging in Meningioma: Prediction of Tumor Grade and Association with Histopathological Parameters.
    Surov A; Gottschling S; Mawrin C; Prell J; Spielmann RP; Wienke A; Fiedler E
    Transl Oncol; 2015 Dec; 8(6):517-23. PubMed ID: 26692534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?
    Li X; Wang H; Gao J; Jiang L; Chen M
    Quant Imaging Med Surg; 2023 Oct; 13(10):7092-7104. PubMed ID: 37869329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility and usefulness of quantitative apparent diffusion coefficient measurements for predicting program death-ligand 1 expression in nasopharyngeal carcinoma.
    Zhong X; Li L; Yin J; Chen Y; Xin X; Yu L; Tang Y; Zhang J; Li J
    Cancer Imaging; 2023 Oct; 23(1):98. PubMed ID: 37828560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial cancer: correlation of apparent diffusion coefficient (ADC) with tumor cellularity and tumor grade.
    Kishimoto K; Tajima S; Maeda I; Takagi M; Ueno T; Suzuki N; Nakajima Y
    Acta Radiol; 2016 Aug; 57(8):1021-8. PubMed ID: 26486600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of menstrual status and pathological type on the apparent diffusion coefficient in cervical cancer: a primary study.
    Dong Y; Dong RT; Zhang XM; Song QL; Yu T; Hong Luo Y
    Acta Radiol; 2021 Mar; 62(3):430-436. PubMed ID: 32536261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas.
    Mahmoud OM; Tominaga A; Amatya VJ; Ohtaki M; Sugiyama K; Sakoguchi T; Kinoshita Y; Takeshima Y; Abe N; Akiyama Y; El-Ghoriany AI; Abd Alla AK; El-Sharkawy MA; Arita K; Kurisu K; Yamasaki F
    Eur J Radiol; 2011 Nov; 80(2):412-7. PubMed ID: 20580505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion for Differentiating among Glioblastoma, Metastasis, and Lymphoma Focusing on Diffusion-Related Parameter.
    Shim WH; Kim HS; Choi CG; Kim SJ
    PLoS One; 2015; 10(7):e0134761. PubMed ID: 26225937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantage of High b Value Diffusion-Weighted Imaging for Differentiation of Hemangioblastoma from Brain Metastases in Posterior Fossa.
    Onishi S; Hirose T; Takayasu T; Nosaka R; Kolakshyapati M; Saito T; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
    World Neurosurg; 2017 May; 101():643-650. PubMed ID: 28179177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.